Volume 20, Issue 5 (Sep 2018)
Treatment strategy for metastatic prostate cancer with extremely high PSA level: reconsidering the value of vintage therapy
Yasutaka Yamada1,2, Shinichi Sakamoto2, Yoshiyasu Amiya1, Makoto Sasaki1, Takayuki Shima1, Akira Komiya2, Noriyuki Suzuki1, Koichiro Akakura3, Tomohiko Ichikawa2, Hiroomi Nakatsu1
Asian J Androl 20: 432-437; 10.4103/aja.aja_24_18
Abstract |Full Text | PDF PDF

Using the prostate imaging reporting and data system version 2 (PI-RIDS v2) to detect prostate cancer can prevent unnecessary biopsies and invasive treatment
Chang Liu1, Shi-Liang Liu1, Zhi-Xian Wang1, Kai Yu1, Chun-Xiang Feng1, Zan Ke2, Liang Wang2, Xiao-Yong Zeng1
Asian J Androl 20: 459-464; 10.4103/aja.aja_19_18
Abstract |Full Text | PDF PDF

The novel long noncoding RNA LOC283070 is involved in the transition of LNCaP cells into androgen-independent cells via its interaction with PHB2
Ying Zhang1, Li-Na Wang2, Ya-Ni Lin1, Yuan-Xin Xing1, Yu Shi3, Jian Zhao4, Wei-Wen Chen1, Bo Han5
Asian J Androl 20: 511-517; 10.4103/aja.aja_36_18
Abstract |Full Text | PDF PDF

Volume 20, Issue 4 (Jul 2018)
Evaluation of PSA-age volume score in predicting prostate cancer in Chinese population
Yi-Shuo Wu1,2, Xiao-Bo Wu1,2, Ning Zhang1,2, Guang-Liang Jiang1,2, Yang Yu1, Shi-Jun Tong1,2, Hao-Wen Jiang1,2, Shan-Hua Mao1,2, Rong Na2,3, Qiang Ding1,2
Asian J Androl 20: 324-329; 10.4103/aja.aja_81_17
Abstract |Full Text | PDF PDF

The performance of the new prognostic grade and stage groups in conservatively treated prostate cancer
Cheng Chen1, Ye Chen2, Lin-Kun Hu3, Chang-Chuan Jiang4, Ren-Fang Xu1, Xiao-Zhou He1
Asian J Androl 20: 366-371; 10.4103/aja.aja_5_18
Abstract |Full Text | PDF PDF

Hormone levels following surgical and medical castration: defining optimal androgen suppression
Michael T Schweizer1,2, Michael L Hancock, Robert H Getzenberg3, Evan Y Yu1,2
Asian J Androl 20: 405-406; 10.4103/aja.aja_38_17
Full Text | PDF PDF

The prevalence and risk factors of prostatic calcification: an analysis of 68 705 subjects
Zhuang Tang1,2, Xiao-Mei Wu3, Qiang Wei1,2, Lin-Na Wu3
Asian J Androl 20: 417-419; 10.4103/aja.aja_41_17
Full Text | PDF PDF

Volume 20, Issue 3 (May 2018)
The path forward in prostate cancer therapeutics
Jeanny B Aragon-Ching1, Ravi A Madan2
Asian J Androl 20: 213-214; DOI: 10.4103/aja.aja_3_18
Full Text | PDF PDF

Bone-targeted therapies to reduce skeletal morbidity in prostate cancer
Tanya B Dorff1, Neeraj Agarwal2
Asian J Androl 20: 215-220; 10.4103/aja.aja_12_18
Abstract |Full Text | PDF PDF

Role of chemotherapy in prostate cancer
Rita Nader1, Joelle El Amm2, Jeanny B Aragon-Ching3
Asian J Androl 20: 221-229; 10.4103/aja.aja_40_17
Abstract |Full Text | PDF PDF